CD36 and chronic kidney disease: We also observed a modest impact of inflammation potentially triggered by uremic toxicity in arteries (both in a non-invasive evaluation-observed specifically for CD36 as well as in tissue—particularly related to CX3CR1) and its association with mortality (taking into consideration the limitations imposed by the potential lack of power of the survival analysis) in this group of CKD patients.